Serum Fibrosis Markers for the Diagnosis of Liver Disease Among People With Chronic Hepatitis C in Chennai, India

Background. Access to hepatitis C virus (HCV) treatment is limited in low- and middle-income countries (LMICs). Noninvasive biomarkers, such as fibrosis 4 (FIB-4) and aminotransferase to platelet ratio index (APRI), are low-cost alternatives to staging liver disease and identifying treatment need in...

Descripción completa

Detalles Bibliográficos
Autores principales: Cepeda, Javier A., Solomon, Sunil S., Srikrishnan, Aylur K., Nandagopal, Paneerselvam, Balakrishnan, Pachamuthu, Kumar, Muniratnam S., Thomas, David L., Sulkowski, Mark S., Mehta, Shruti H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047433/
https://www.ncbi.nlm.nih.gov/pubmed/27704012
http://dx.doi.org/10.1093/ofid/ofw156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047433/
https://www.ncbi.nlm.nih.gov/pubmed/27704012
http://dx.doi.org/10.1093/ofid/ofw156

Ejemplares similares